Development and Validation of a Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed Epilepsy
Authors:
Top Cited Papers
Open Access
- 1 October 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (10) , 986-996
Abstract
Epilepsy affects 50 million people worldwide.1 The treatment goal for newly diagnosed epilepsy is seizure freedom, usually defined as no seizures for 12 months or more,2 achieved as soon as possible with minimal or no treatment-related adverse effects. This goal is achieved using antiseizure medications (ASMs), which suppress the occurrence of seizures without modifying the underlying pathology.3 Choosing the first ASM is of paramount importance because an inadequate response to the first prescribed drug is a strong predictor of poor subsequent long-term outcome.4-6 A proportion of patients whose first ASM treatment fails will respond to subsequent treatments,6 which implies that they might have become seizure free sooner if they were given the “right drug” at the outset.Keywords
This publication has 53 references indexed in Scilit:
- Patterns of treatment response in newly diagnosed epilepsyNeurology, 2012
- A population‐based study of long‐term outcome of epilepsy in childhood with a focal or hemispheric lesion on neuroimagingEpilepsia, 2011
- A multilayer perceptron neural network-based approach for the identification of responsiveness to interferon therapy in multiple sclerosis patientsInformation Sciences, 2010
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Diagnosing refractory epilepsy: response to sequential treatment schedulesEuropean Journal of Neurology, 2006
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- Support vector machinesIEEE Intelligent Systems and their Applications, 1998
- A Tutorial in Logistic RegressionJournal of Marriage and Family, 1995